{"id":348057,"date":"2025-08-27T17:06:11","date_gmt":"2025-08-27T17:06:11","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/348057\/"},"modified":"2025-08-27T17:06:11","modified_gmt":"2025-08-27T17:06:11","slug":"sciences-a-strasbourg-un-vaccin-personnalise-contre-le-cancer-affiche-des-resultats-inedits","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/348057\/","title":{"rendered":"Sciences. \u00c0 Strasbourg, un vaccin personnalis\u00e9 contre le cancer affiche des r\u00e9sultats in\u00e9dits"},"content":{"rendered":"<p>Dans les cancers ORL, plus d\u2019un patient sur trois rechute dans les deux ans et l\u2019immunoth\u00e9rapie actuelle reste peu efficace. Les malades ayant re\u00e7u les injections du vaccin d\u00e9velopp\u00e9 par Transgene, et baptis\u00e9 TG4050, sont tous en r\u00e9mission clinique\u00a0: aucun n\u2019a rechut\u00e9 apr\u00e8s un suivi m\u00e9dian de 30 mois.<\/p>\n<p>\u00ab\u00a0Il est tr\u00e8s rare d\u2019obtenir de telles donn\u00e9es\u00a0\u00bb, s\u2019est f\u00e9licit\u00e9 mercredi 27\u00a0ao\u00fbt Alessandro Riva, pr\u00e9sident-directeur g\u00e9n\u00e9ral de la soci\u00e9t\u00e9 strasbourgeoise, lors de la pr\u00e9sentation des r\u00e9sultats.<\/p>\n<p>La phase 1 de l\u2019essai clinique <a href=\"https:\/\/www.dna.fr\/sante\/2021\/01\/21\/transgene-teste-un-vaccin-therapeutique\" target=\"_blank\" rel=\"noopener\">lanc\u00e9 en 2019 par Transgene<\/a> a port\u00e9 sur 32 patients \u00e0 un stade pr\u00e9coce de la&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"Dans les cancers ORL, plus d\u2019un patient sur trois rechute dans les deux ans et l\u2019immunoth\u00e9rapie actuelle reste&hellip;\n","protected":false},"author":2,"featured_media":348058,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2820],"tags":[1111,11,2389,2649,33,2880,1777,674,107,1011,27,5325,2798,775,5015,12,25,71,767,4604,640,2879],"class_list":{"0":"post-348057","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-strasbourg","8":"tag-actu","9":"tag-actualites","10":"tag-alsace","11":"tag-bas-rhin","12":"tag-economie","13":"tag-edition-strasbourg","14":"tag-eu","15":"tag-europe","16":"tag-fil-info","17":"tag-fr","18":"tag-france","19":"tag-galerie-media","20":"tag-galerie-photo","21":"tag-grand-est","22":"tag-innovation-et-start-up","23":"tag-news","24":"tag-republique-francaise","25":"tag-sante","26":"tag-science-et-technologie","27":"tag-selection-abonne","28":"tag-strasbourg","29":"tag-strasbourg-ville"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115101826017910479","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/348057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=348057"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/348057\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/348058"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=348057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=348057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=348057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}